Calculators

401k Retirement Calculator Mortgage Calculator

New

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Pharmadrug (TSE:PHRX)

CNQX:PHRX

PHRX

Pharmadrug

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Pharmadrug (PHRX) Income Statement

30 Followers

Pharmadrug Income Statement

Last quarter (Q3 2023), Pharmadrug's total revenue was C$―, a decrease of -100.00% from the same quarter last year. In Q3, Pharmadrug's net income was C$-300.01K. See Pharmadrug’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	C$ -105.21K	-	C$ 494.99K	C$ 683.67K	C$ 610.58K	C$ 0.00
Cost of Revenue	C$ -80.77K	C$ 2.26K	C$ 394.13K	C$ 501.63K	C$ 357.32K	C$ 0.00
Gross Profit	C$ -24.44K	C$ -2.26K	C$ 100.86K	C$ 182.04K	C$ 253.25K	C$ 0.00
Operating Expense	C$ 386.04K	C$ 2.42M	C$ 5.22M	C$ 4.02M	C$ 5.35M	C$ 950.52K
Operating Income	C$ -410.48K	C$ -2.42M	C$ -5.12M	C$ -3.84M	C$ -5.09M	C$ -950.52K
Net Non Operating Interest Income Expense	C$ -273.51K	C$ -223.31K	C$ 156.36K	C$ 321.29K	C$ -476.99K	C$ -188.04K
Other Income Expense	C$ 301.53K	C$ 611.83K	C$ -1.43M	C$ -1.74M	C$ -1.41M	C$ -2.37M
Pretax Income	C$ 1.88M	C$ -3.25M	C$ -6.71M	C$ -5.90M	C$ -6.98M	C$ -3.51M
Tax Provision	C$ -100.05K	C$ -190.00K	C$ -833.55K	C$ -475.01K	C$ -442.75K	C$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -1.48M	C$ -8.88M	C$ -5.63M	C$ -5.15M	C$ -6.29M	C$ -3.89M
Basic EPS	C$ -0.01	C$ -0.03	C$ -0.02	C$ -0.04	C$ -0.09	C$ -0.29
Diluted EPS	C$ -0.01	C$ -0.03	C$ -0.02	C$ -0.04	C$ -0.09	C$ -0.29
Basic Average Shares	C$ 1.12B	C$ 350.66M	C$ 331.18M	C$ 142.46M	C$ 70.11M	C$ 13.75M
Diluted Average Shares	C$ 1.12B	C$ 350.66M	C$ 331.18M	C$ 142.46M	C$ 70.11M	C$ 13.75M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 305.28K	C$ 2.42M	C$ -5.62M	C$ -4.52M	C$ 5.70M	C$ 950.52K
Net Income From Continuing And Discontinued Operation	C$ -1.48M	C$ -8.88M	C$ -5.63M	C$ -5.15M	C$ -6.29M	C$ -3.89M
Normalized Income	C$ -438.39K	C$ -3.44M	C$ -7.54M	C$ -2.04M	C$ -4.97M	C$ -1.14M
Interest Expense	-	-	-	-	C$ 476.99K	C$ 188.04K
EBIT	C$ 2.15M	C$ -3.03M	C$ -6.55M	C$ -5.55M	C$ -6.50M	C$ -3.32M
EBITDA	C$ 1.90M	C$ -2.98M	C$ -5.27M	C$ -4.25M	C$ -5.73M	C$ -3.32M

Currency in CAD

Pharmadrug Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing